Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK.
Al-Batran, Salah-Eddin, Pauligk, Claudia, Hofheinz, Ralf, Lorenzen, Sylvie, Wicki, Andreas, Siebenhuener, Alexander Rheinhard, Schenk, Michael, Welslau, Manfred, Heuer, Vera, Goekkurt, Eray, Schmalenberg, Harald, Thuss-Patience, Peter C., Waberer, Lisa, Talbot, Jonathan, Goetze, Thorsten Oliver and Homann, Nils (2019) Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK. Journal of Clinical Oncology 37 (15_sup), TPS4142-TPS4142.Date of publication of this fulltext: 03 Sep 2021 10:02
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Clinical Oncology | ||||
| Volume: | 37 | ||||
|---|---|---|---|---|---|
| Number of Issue or Book Chapter: | 15_sup | ||||
| Page Range: | TPS4142-TPS4142 | ||||
| Date | 2019 | ||||
| Institutions | UNSPECIFIED | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | UNSPECIFIED | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 48662 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric